In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer

被引:49
作者
Fiumara, A
Belfiore, A
Russo, G
Salomone, E
Santonocito, GM
Ippolito, O
Vigneri, R
Gangemi, P
机构
[1] UNIV CATANIA, IST MED INTERNA & MALATTIE ENDOCRINE & METAB, CATTEDRA ENDOCRINOL, I-95123 CATANIA, ITALY
[2] UNIV CATANIA, PRESIDIO OSPED VITTORIO EMANUELE II, SERV ANAT & ISTOL PATOL, I-95123 CATANIA, ITALY
[3] UNIV CATANIA, CATTEDRA CHIRURG, I-95123 CATANIA, ITALY
关键词
D O I
10.1210/jc.82.5.1615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the occurrence, tissue distribution, and prognostic Value of tumor-associated macrophages in 121 papillary thyroid carcinomas using immunohistochemical staining with anti-CD68 antibody in archival paraffin-embedded sections. Lymphocytic infiltration and dendritic cell presence were also evaluated. Three groups were identified according to the presence and characteristics of macrophages: 1) tumors without evidence of infiltrating macrophages: (n = 35); 2) tumors with infiltrating macrophages but no evidence of neoplastic cells phagocytosis (n = 68); and 3) tumors with infiltrating macrophages and in situ evidence of active neoplastic cell phagocytosis (n = 18). Neoplastic cell phagocytosis by macrophages was positively correlated with both lymphocytic infiltration and dendritic cells (P = 0.0000), whereas it was negatively correlated with vascular invasion (P = 0.0032). Distant metastases developed in none of the 18 tumors with neoplastic cell phagocytosis, but occurred in 15 of 103 of the remaining tumors (P = 0.0647) and were significantly and negatively associated with lymphocytic infiltration or dendritic cells. The present study indicates, therefore, that immune reaction, involving neoplastic cell phagocytosis by macrophages and lymphocytic infiltration, plays a role in the development of distant metastases in patients with papillary thyroid cancer.
引用
收藏
页码:1615 / 1620
页数:6
相关论文
共 30 条
[1]  
ALLEN CA, 1987, CANCER RES, V47, P2919
[2]  
[Anonymous], ENDOCRINE TUMORS
[3]   THE IMMUNE-RESPONSE TO PAPILLARY THYROID-CANCER [J].
BAKER, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3419-3420
[4]   INCREASED AGGRESSIVENESS OF THYROID-CANCER IN PATIENTS WITH GRAVES-DISEASE [J].
BELFIORE, A ;
GAROFALO, MR ;
GIUFFRIDA, D ;
RUNELLO, F ;
FILETTI, S ;
FIUMARA, A ;
IPPOLITO, O ;
VIGNERI, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :830-835
[5]   DENOVO HLA CLASS-II AND ENHANCED HLA CLASS-I MOLECULE EXPRESSION IN SV40 TRANSFECTED HUMAN THYROID EPITHELIAL-CELLS [J].
BELFIORE, A ;
MAUERHOFF, T ;
PUJOLBORRELL, R ;
BADENHOOP, K ;
BUSCEMA, M ;
MIRAKIAN, R ;
BOTTAZZO, GF .
JOURNAL OF AUTOIMMUNITY, 1991, 4 (03) :397-414
[6]  
BISI H, 1989, CANCER, V64, P1888, DOI 10.1002/1097-0142(19891101)64:9<1888::AID-CNCR2820640922>3.0.CO
[7]  
2-C
[8]   The immunology of thyroid cancer [J].
Boyd, CM ;
Baker, JR .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (01) :159-+
[9]  
CLAASEN HHV, 1992, LAB INVEST, V67, P166
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187